Norio Hanafusa
University of Tokyo
Internal medicineUrologyEndocrinologySurgeryRenal functionIntensive care medicineMortality rateImmunologyHazard ratioSurvival rateApheresisCartHemodialysisKidney diseasePlasmapheresisPeritoneal dialysisDiabetic nephropathyDialysisAscitesPopulationNephrologyDiabetes mellitusMedicineGastroenterology
145Publications
23H-index
1,989Citations
Publications 146
Newest
#1Kosaku NittaH-Index: 61
#2Shigeru Nakai (RMIT: RMIT University)H-Index: 30
Last. Hidetomo NakamotoH-Index: 31
view all 15 authors...
According to the annual survey of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) conducted at the end of 2018, a total of 339,841 patients were receiving dialysis (hereinafter, dialysis patients) in Japan. This survey included an investigation of individual test results for hepatitis B surface antigen (HBsAg), hepatitis C virus (HCV) antibody (HCV-Ab), HCV-RNA, and serum alanine aminotransferase (ALT) (glutamic pyruvic transaminase [GPT]). The survey revealed that among dia...
Source
#1Kosaku NittaH-Index: 61
#2Shigeru Nakai (RMIT: RMIT University)H-Index: 30
Last. Junichi HoshinoH-Index: 24
view all 74 authors...
According to the annual survey of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) conducted at the end of 2018, there were a total of 339,841 patients receiving dialysis (hereinafter, dialysis patients) in Japan. The survey included questions regarding the presence/absence of dementia, the performance status (PS), and the exercise habits of individual patients. The survey revealed that 10.8% of all dialysis patients had dementia (1.8% in the age group of less than 65 years, ...
Source
#1Kenichi AkiyamaH-Index: 4
#2Norio HanafusaH-Index: 23
Last. Hiroshi KawaguchiH-Index: 5
view all 14 authors...
Source
#1Tetsuya Ito (UTokyo: University of Tokyo)H-Index: 5
#2Norio HanafusaH-Index: 23
Last. Michio KatoH-Index: 27
view all 7 authors...
BACKGROUND Ascites is one of the most common complications seen in patients with decompensated cirrhosis. Cell-free and concentrated ascites reinfusion therapy (CART) has been performed against cirrhotic ascites, but its safety and efficacy, differences in clinical profiles from CART against malignancy-related ascites with different pathological background still remain unclear. METHODS The present investigation involved a sub-analysis of data obtained from a prospective observational study of CA...
Source
#1Hiroki YabeH-Index: 2
#2Kenichi KonoH-Index: 2
Last. Ken TsuchiyaH-Index: 33
view all 5 authors...
Source
#1Yuka Sugawara (UTokyo: University of Tokyo)H-Index: 1
#2Masao Iwagami (Lond: University of London)H-Index: 9
Last. Masaomi Nangaku (UTokyo: University of Tokyo)H-Index: 80
view all 12 authors...
BACKGROUND: There are no reports of a large-scale survey on the infection prevention measures against coronavirus disease 2019 (COVID-19) in nephrology facilities. This study investigated the facility-level nephrology practices adopted during the COVID-19 pandemic and their associated challenges. Additionally, the treatment patterns and outcomes of chronic kidney disease (CKD) patients with COVID-19 were reviewed. METHODS: We conducted a nationwide questionnaire survey of 704 educational facilit...
Source
#1Takeshi Hasegawa (Showa University)H-Index: 25
#2Junhui ZhaoH-Index: 8
Last. Masaomi Nangaku (UTokyo: University of Tokyo)H-Index: 80
view all 8 authors...
INTRODUCTION Dipeptidyl peptidase-4 (DPP-4) has been hypothesized to improve responsiveness to erythropoiesis-stimulating agent (ESA). We aimed to describe the trend in DPP-4 inhibitor prescription patterns and assess the association between DPP-4 inhibitor prescription and ESA hyporesponsiveness (eHypo) in Japanese hemodialysis (HD) patients with diabetes mellitus (DM). METHODS We analyzed data from the Japan Dialysis Outcomes and Practice Patterns Study phase 4-6 (2009-2017) on patients with D...
Source
#1Suguru Yamamoto (Niigata University)H-Index: 21
#2Brian BieberH-Index: 25
Last. Masafumi Fukagawa (Tokai University)H-Index: 69
view all 11 authors...
Objectives Patients undergoing hemodialysis (HD) may have poor nutritional status and hyperphosphatemia. Nephrologists sometimes manage hyperphosphatemia by prescribing phosphate binders and/or recommending restriction of dietary phosphate including protein-rich foods; the later may, however, adversely affect nutritional status. Design and Methods The analysis includes 8805 HD patients on dialysis ≥ 120 days in 12 countries in Dialysis Outcomes and Practice Patterns Study (DOPPS) phase 4 (2009-2...
Source
#1Ken Ishitani (Kitasato University)H-Index: 11
#2Ayako IsoaiH-Index: 2
Last. Norio HanafusaH-Index: 23
view all 14 authors...
BACKGROUND Cell-free and concentrated ascites reinfusion therapy (CART) has been suggested to be able to treat malignant ascites more safely and effectively with chemotherapy because of its ability to retain serum protein and albumin. Although the characteristics of cancer types and CART and the clinical implications of combination therapy with antitumor agents are becoming widespread, there are limited reports on its efficacy and complications. METHODS In this prospective observational national...
Source
#2Teppei OmoriH-Index: 7
Last. Katsutoshi TokushigeH-Index: 40
view all 12 authors...
Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is now a pandemic. Although several treatment guidelines have been proposed for patients who have both inflammatory bowel disease and COVID-19, immunosuppressive therapy is essentially not recommended, and the treatment options are limited. Even in the COVID-19 pandemic, adjuvant adsorptive granulocyte and monocyte apheresis may safely bring ulcerative colitis (UC) into rem...
Source